The company’s board of directors has named Kevin Smith as Inogen’s new president and CEO, effective immediately. Smith succeeds Nabil Shabshab, who started as CEO in 2021.
Smith has over two decades of experience in the medical device sector, including in respiratory care and durable medical equipment. His most recent role was CEO at Sirtex Medical, a manufacturer of interventional treatment solutions. He’s held senior roles at Sensium Healthcare, Teleflex, Hillrom Holdings and Zoll Medical.
“We believe we have tremendous opportunities to scale our business, drive operational efficiencies and accelerate our growth trajectory, and the board believes it is the right time for new leadership to improve performance and support Inogen’s next phase of its journey,” Elizabeth Mora, chair of Inogen’s board, said in a news release.
“With deep global medical device experience and a strong track record of successful business transformations, we believe Kevin is the right leader to capitalize on Inogen’s potential. We look forward to benefitting from his expertise as we seek to advance our commercial strategy, win new customers, and drive sustainable, long-term value for our shareholders.”
Smith described Inogen as a company with a strong brand, global reach, and purpose-led vision. “I believe Inogen has a solid foundation, with leading products, and significant potential to make innovative respiratory solutions the standard of care to improve patient health.”
Mora also thanked Shabshab for his service and contributions to Inogen. “Nabil has helped navigate Inogen through headwinds over the past few years, and we wish him well in his future endeavors.”
